Essential medicines for childhood cancer in Europe: a pan-European, systematic analysis by SIOPEMaria Otth, Elena Oltenau, Eva Brack et al.|The Lancet Oncology|2022Cited by 10
New models for the development of and access to CAR T-cell therapies for children and adolescents with cancer: an ACCELERATE multistakeholder analysisAndrew D.J. Pearson, Gilles Vassal, André Baruchel et al.|The Lancet Oncology|2025Cited by 9